FP
SRGA

Foundry Partners’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Foundry Partners’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,555
Closed -$1.24M – 423
2019
Q3 		$1.24M Sell
14,555
-816
-5% -$87.1K 0.05% 303
2019
Q2 		$1.96M Sell
15,371
-2,742
-15% -$395K 0.08% 261
2019
Q1 		$3.27M Sell
18,113
-11,957
-40% -$1.73M 0.13% 220
2018
Q4 		$3.34M Sell
30,070
-399
-1% -$52K 0.15% 208
2018
Q3 		$4.11M Sell
30,469
-4,398
-13% -$606K 0.16% 215
2018
Q2 		$4.81M Buy
34,867
+91
+0.3% +$12.5K 0.2% 201
2018
Q1 		$4.8M Sell
34,776
-2,149
-6% -$292K 0.2% 179
2017
Q4 		$4.54M Buy
36,925
+9,744
+36% +$1.34M 0.19% 192
2017
Q3 		$3.71M Sell
27,181
-967
-3% -$146K 0.15% 240
2017
Q2 		$4.94M Sell
28,148
-6,495
-19% -$924K 0.2% 177
2017
Q1 		$4.16M Buy
34,643
+1,737
+5% +$181K 0.17% 218
2016
Q4 		$3.21M Buy
+32,906
New +$3.02M 0.14% 248

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM

Foundry Partners's SRGA Position: Q4 2019 in Review

Foundry Partners sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2019, closing a stake of 14,555 shares — an estimated $1.24M sold.

Foundry Partners first reported a position in SRGA in Q4 2016 and held it in 12 quarters. The position peaked at $4.94M in Q2 2017. 88 funds tracked by Wall St. Rank hold SRGA as of Q4 2019.

  • Foundry Partners reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Foundry Partners sold 14,555 Surgalign Holdings, Inc. Common Stock shares in Q4 2019, an estimated $1.24M.
  • Foundry Partners first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2016 and held it in 12 quarters.
  • Foundry Partners's Surgalign Holdings, Inc. Common Stock position peaked at $4.94M in Q2 2017.
  • 88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2019.

Based on Foundry Partners's 13F filing for Q4 2019, filed 10 Feb 2020.